Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy

NCT07124065 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07124065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07124065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Active, not recruiting
Start date
March 20, 2024
Completion date
March 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nodule solitary thyroid, thyroid cancer